| Summary: | Dejene Debela Snr,1– 3 Elias Ababulgu,4 Gaddisa Desu,1,4 Serkaddis Abebe,1 Tesfaye Adugna1,4 1Department of Internal Medicine, Fromsis Primary Hospital (FPH), Jimma, Oromia, Ethiopia; 2Department of Quality Improvement Unit, Shenen Gibe General Hospital, Jimma, Oromia, Ethiopia; 3Department of Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 4Jimma University Medical Center (JUMC), Jimma, Oromia, EthiopiaCorrespondence: Dejene Debela Addis Ababa, 9086, EthiopiaTel +251913910868Email dejene.tolossa@aau.edu.etBackground: Deep vein thrombosis (DVT) is commonly identified and diagnosed in the emergency department. Factors including sedentary life (immobility), pregnancy in women, cancer, postoperation, admission to ICU, smoking, and obesity are identified risks for thrombosis development. We report a case of a 35-year-old man who presented to the emergency department developing left lower leg swelling and pain, low-grade fever, and headache after he was treated and discharged, cured of severe COVID-19. Then venous and arterial Doppler ultrasound of the lower leg revealed dilated, absent flow and luminal thrombus in the distal popliteal, anterior and posterior tibial veins and perforator vessels were diagnosed as leg DVT.Conclusion: DVT is a hematological emergency that needs serious consideration in prevention as well early diagnosis in patients with possible risk factors. This case report aims to arouse the clinician’s awareness of the occurrence of deep vein thrombosis during and after COVID-19.Keywords: post-COVID-19, thromboembolism, hypercoagulability, antithrombotic drugs
|
|---|
